Teleflex Incorporated

TFX

$139.96

-0.72%

2026-09-03 16:00:03 EDT-$1.01

Healthcare

Medical - Instruments & Supplies

NYSE

Active Trading

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial ...

Recent News of TFX

Defense World7/27/2026Neutral

California Public Employees Retirement System Has $6.79 Million Stock Holdings in Teleflex Incorporated $TFX

California Public Employees Retirement System reduced its stake in shares of Teleflex Incorporated (NYSE: TFX) by 30.6% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,778 shares of the medical technology company's stock after selling

Business Wire7/23/2026Neutral

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 6, 2026. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.com. An audio replay of the call will be available beginning.

Defense World7/23/2026Neutral

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Hold” from Brokerages

Teleflex Incorporated (NYSE: TFX - Get Free Report) has earned an average rating of "Hold" from the eleven research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, four have given a buy rating and one has given a

GuruFocus7/21/2026Neutral

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1

Business Wire7/21/2026Neutral

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions. “As healthcare sys.

Teleflex Incorporated

Recent News of TFX

California Public Employees Retirement System Has $6.79 Million Stock Holdings in Teleflex Incorporated $TFX

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Hold” from Brokerages

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

California Public Employees Retirement System Has $6.79 Million Stock Holdings in Teleflex Incorporated $TFX

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Hold” from Brokerages

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Bessemer Group Inc. Grows Stake in Teleflex Incorporated $TFX

Teleflex Publishes 2025 Global Impact Report

Do Options Traders Know Something About Teleflex Stock We Don't?

Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Divestitures: What Investors Should Watch in 2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Announces Quarterly Dividend

TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash

Teleflex Incorporated (TFX) Q1 2026 Earnings Call Transcript

Compared to Estimates, Teleflex (TFX) Q1 Earnings: A Look at Key Metrics

Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates

Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

Teleflex (TFX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Teleflex Appoints Jason Weidman as President and CEO

Supply Chain of TFX

Upstream

Downstream

Proxies

Recent News of TFX

California Public Employees Retirement System Has $6.79 Million Stock Holdings in Teleflex Incorporated $TFX

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Hold” from Brokerages

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

California Public Employees Retirement System Has $6.79 Million Stock Holdings in Teleflex Incorporated $TFX

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Hold” from Brokerages

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Bessemer Group Inc. Grows Stake in Teleflex Incorporated $TFX

Teleflex Publishes 2025 Global Impact Report

Do Options Traders Know Something About Teleflex Stock We Don't?

Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Divestitures: What Investors Should Watch in 2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Announces Quarterly Dividend

TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash

Teleflex Incorporated (TFX) Q1 2026 Earnings Call Transcript

Compared to Estimates, Teleflex (TFX) Q1 Earnings: A Look at Key Metrics

Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates

Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

Teleflex (TFX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Teleflex Appoints Jason Weidman as President and CEO

Supply Chain of TFX

Upstream

Downstream

Proxies